Nonalcoholic Steatohepatitis Care Act of 2020 or the NASH Care Act of 2020
This bill reauthorizes, establishes, or expands various grants, research, disease surveillance, and other efforts to prevent, diagnose, and treat nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (i.e., liver inflammation and damage caused by a buildup of fat in the liver).
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.